All 1 tracked stories fall under one category: earnings. Of the tracked stories, 1 of 1 also mention American Tower, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6 for that window. They are less corroborated than the beat average, carrying 2 original sources each against 2.6 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Avanos Medical
All 1 tracked stories fall under one category: earnings. Of the tracked stories, 1 of 1 also mention American Tower, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6 for that window. They are less corroborated than the beat average, carrying 2 original sources each against 2.6 for the same window. We currently track 1 Finance story that mention Avanos Medical, all published on February 26, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 120 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Avanos Medical. Shared-story counts are live from our verified record — not editorial picks.
Avanos Medical (AVNS) reported a strong 2025 finish with sales exceeding revised targets, driven by its Specialty Nutrition Systems segment. In contrast, American Tower (AMT) faces a challenging 2026 outlook due to a payment default by DISH and increased international churn.
Avanos Medical is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.